id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-277992-49mantab	Harikrishnan, S.	Cardiological society of India position statement on COVID-19 and heart failure	2020-05-13		.txt	text/plain	2472	165	48	The following were reported in CMR in one of the patients with myopericarditis who had ventricular systolic dysfunction : increased wall thickness with diffuse biventricular hypokinesis, especially in the apical segments, marked biventricular myocardial interstitial edema, and diffuse late gadolinium enhancement involving the entire biventricular wall 18 Cardiological Society of India recommends fibrinolytics and pharmacological therapy as treatment of choice in stable STEMI. COVID-19 patients who are diagnosed as having asymptomatic left ventricular systolic dysfunction or clinically overt heart failure should receive standard guideline directed therapy.Careful management of fluid balance, careful monitoring of electrolytes and renal function is very important.Another cardiovascular co-morbidity which can co-exist is venous thromboembolism and adequate prophylactic measures need to be undertaken 13 . Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF HEART TRANSPLANT RECIPIENTS DURING THE 2019 CORONAVIRUS OUTBREAK IN WUHAN, CHINA: A DESCRIPTIVE SURVEY REPORT	./cache/cord-277992-49mantab.txt	./txt/cord-277992-49mantab.txt